CollPlant Biotechnologies Ltd.

14.5000.00Vol 5.89K1Y Perf 27.66%
Apr 23rd, 2021 10:53 DELAYED
BID14.21 ASK14.50
Open14.51 Previous Close14.49
Pre-Market- After-Market-
 - -%  - -
Target Price
23.00 
Analyst Rating
Strong Buy 1.00
Potential %
58.62 
Finscreener Ranking
★★     46.60
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     38.17
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     44.37
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap82.22M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
46.55 
Earnings Date
26th May 2021

Today's Price Range

14.4714.51

52W Range

6.0024.26

5 Year PE Ratio Range

-2.50-2.50

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.35%
1 Month
18.27%
3 Months
-0.62%
6 Months
107.74%
1 Year
27.66%
3 Years
159.86%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CLGN14.500.00000.00
AAPL133.701.76001.33
GOOG2 295.3827.46001.21
MSFT259.582.41000.94
XOM55.750.48000.87
WFC43.600.90002.11
JNJ165.930.75000.45
FB298.842.32000.78
GE13.520.11000.82
JPM149.822.45001.66
Financial StrengthValueIndustryS&P 500US Markets
1.30
1.70
0.40
0.76
-131.00
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
51.10
-143.60
-132.60
-2 291.40
-73.23
RevenueValueIndustryS&P 500US Markets
5.53M
0.56
114.75
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.30-0.42-40.00
Q03 20200.920.07-92.39
Q02 2020-0.25-0.2020.00
Q01 2020-0.50-0.2648.00
Q04 2019-0.13-0.88-576.92
Q03 2019-0.26-0.41-57.69
Q02 2019-0.41-0.379.76
Q01 2019-0.41-0.2734.15
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.50292.31Positive
6/2021 QR-0.06-200.00Negative
12/2021 FY1.01274.07Positive
12/2022 FY1.424.41Positive
Next Report Date26th May 2021
Estimated EPS Next Report0.50
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume5.89K
Shares Outstanding5.67M
Trades Count29
Dollar Volume9.35M
Avg. Volume114.61K
Avg. Weekly Volume36.13K
Avg. Monthly Volume42.21K
Avg. Quarterly Volume131.82K

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) stock closed at 14.5 per share at the end of the most recent trading day (a -0.07% change compared to the prior day closing price) with a volume of 16.46K shares and market capitalization of 82.22M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 38 people. CollPlant Biotechnologies Ltd. CEO is Yehiel Tal.

The one-year performance of CollPlant Biotechnologies Ltd. stock is 27.66%, while year-to-date (YTD) performance is 34.63%. CLGN stock has a five-year performance of %. Its 52-week range is between 6 and 24.26, which gives CLGN stock a 52-week price range ratio of 46.55%

CollPlant Biotechnologies Ltd. currently has a PE ratio of -16.40, a price-to-book (PB) ratio of 31.69, a price-to-sale (PS) ratio of 25.99, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -51.22%, a ROC of -96.81% and a ROE of -129.35%. The company’s profit margin is -73.23%, its EBITDA margin is -132.60%, and its revenue ttm is $5.53 Million , which makes it $0.56 revenue per share.

Of the last four earnings reports from CollPlant Biotechnologies Ltd., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.50 for the next earnings report. CollPlant Biotechnologies Ltd.’s next earnings report date is 26th May 2021.

The consensus rating of Wall Street analysts for CollPlant Biotechnologies Ltd. is Strong Buy (1), with a target price of $23, which is +58.62% compared to the current price. The earnings rating for CollPlant Biotechnologies Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CollPlant Biotechnologies Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CollPlant Biotechnologies Ltd. has a Buy technical analysis rating based on Technical Indicators (ADX : 25.16, ATR14 : 1.29, CCI20 : 80.96, Chaikin Money Flow : 0.35, MACD : -0.49, Money Flow Index : 48.77, ROC : 4.32, RSI : 44.23, STOCH (14,3) : 87.91, STOCH RSI : 0.98, UO : 72.63, Williams %R : -12.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CollPlant Biotechnologies Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd is a regenerative medicine company. It is focused on developing and commercializing tissue repair products, initially for 3D-bio printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets. Its products are based on recombinant human collagen produced from genetically-modified tobacco plants, and the company focuses on orthopedics and advanced wound care.

CEO: Yehiel Tal

Telephone: +972 732325600

Address: 4 Oppenheimer Street, Rehovot 7670104, , IL

Number of employees: 38

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

48%52%

Bearish Bullish

48%52%

News

Stocktwits